Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.44
-0.11 (-1.68%)
May 18, 2026, 4:00 PM EDT - Market closed
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $588.44 million as of May 19, 2026. Its market cap has decreased by -32.21% in one year.
Market Cap
588.44M
Enterprise Value
539.45M
1-Year Change
-32.21%
Ranking
Category
Stock Price
$6.44
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $588.44M, an increase of 14.17%. That is a compound annual growth rate of 5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 588.44M | -8.30% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 650.86M |
| Sutro Biopharma | 645.65M |
| Candel Therapeutics | 642.58M |
| Aclaris Therapeutics | 631.28M |
| CorMedix | 592.31M |
| First Tracks Biotherapeutics | 589.68M |
| Forte Biosciences | 586.10M |
| Arvinas | 585.85M |